Follow the people · Insider
Anatol Kreitzer
Anatol Kreitzer files insider transactions with the SEC as a chief discovery officer of MapLight Therapeutics (MPLT). We hold 5 disclosed purchases and sales filed since 28 October 2025, 3 of them in the last 90 days.
- Files forMPLT
- Disclosed buys and sells5 in all, 3 in the last 90 days
- Last disclosure19 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 27 October 2025 — 17 August 2026Chief Discovery Officer · MapLight Therapeutics (MPLT)21 Form 4 lines · source: SEC Form 4
Everything they disclosed
21 entries, newest first — one per disclosure report, one per Form 4 line- was granted 6,020 shares of MapLight TherapeuticsSEC Form 419 August 2026Voting Common Stock · traded 17 August 2026 · filed 19 August 2026
- was granted 24,455 shares of MapLight Therapeutics (a derivative holding)SEC Form 419 August 2026Employee Stock Option (right to buy) · traded 17 August 2026 · filed 19 August 2026
- ▼ sold on the open market 5,545 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 15 July 2026 · filed 20 July 2026
- ▼ sold on the open market 4,510 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 15 July 2026 · filed 20 July 2026
- ▼ sold on the open market 7,464 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 16 July 2026 · filed 20 July 2026
- ▼ sold on the open market 1,592 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 16 July 2026 · filed 20 July 2026
- ▼ sold on the open market 2,833 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 17 July 2026 · filed 20 July 2026
- ▼ sold on the open market 14,140 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 17 July 2026 · filed 20 July 2026
- ▼ sold on the open market 200 shares of MapLight TherapeuticsSEC Form 420 July 2026Voting Common Stock · traded 17 July 2026 · filed 20 July 2026
- ▼ sold on the open market 8,346 shares of MapLight TherapeuticsSEC Form 429 April 2026Voting Common Stock · traded 27 April 2026 · filed 29 April 2026
- ▼ sold on the open market 29,255 shares of MapLight TherapeuticsSEC Form 429 April 2026Voting Common Stock · traded 27 April 2026 · filed 29 April 2026
- ▼ sold on the open market 7,821 shares of MapLight TherapeuticsSEC Form 429 April 2026Voting Common Stock · traded 27 April 2026 · filed 29 April 2026
- ▼ sold on the open market 3,316 shares of MapLight TherapeuticsSEC Form 417 April 2026Voting Common Stock · traded 15 April 2026 · filed 17 April 2026
- was granted 6,020 shares of MapLight TherapeuticsSEC Form 49 February 2026Voting Common Stock · traded 5 February 2026 · filed 9 February 2026
- was granted 24,455 shares of MapLight Therapeutics (a derivative holding)SEC Form 49 February 2026Employee Stock Option (right to buy) · traded 5 February 2026 · filed 9 February 2026
- was granted 24,455 shares of MapLight Therapeutics (a derivative holding)SEC Form 49 February 2026Employee Stock Option (right to buy) · traded 5 February 2026 · filed 9 February 2026
- was granted 6,020 shares of MapLight TherapeuticsSEC Form 49 February 2026Voting Common Stock · traded 5 February 2026 · filed 9 February 2026
- had shares withheld for tax on 42,099 shares of MapLight TherapeuticsSEC Form 429 January 2026Voting Common Stock · traded 27 January 2026 · filed 29 January 2026
- had shares withheld for tax on 42,099 shares of MapLight TherapeuticsSEC Form 429 January 2026Voting Common Stock · traded 27 January 2026 · filed 29 January 2026
- was granted 146,052 shares of MapLight Therapeutics (a derivative holding)SEC Form 428 October 2025Employee Stock Option (right to buy) · traded 27 October 2025 · filed 28 October 2025
- was granted 35,953 shares of MapLight TherapeuticsSEC Form 428 October 2025Voting Common Stock · traded 27 October 2025 · filed 28 October 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.